BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 4145369)

  • 41. Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor.
    O'Reilly RJ; Dupont B; Pahwa S; Grimes E; Smithwick EM; Pahwa R; Schwartz S; Hansen JA; Siegal FP; Sorell M; Svejgaard A; Jersild C; Thomsen M; Platz P; L'Esperance P; Good RA
    N Engl J Med; 1977 Dec; 297(24):1311-8. PubMed ID: 21351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells.
    Kedar E; Bonavida B
    J Immunol; 1974 Oct; 113(4):1386-9. PubMed ID: 4153487
    [No Abstract]   [Full Text] [Related]  

  • 43. European experience with fetal tissue transplantation in severe combined immunodeficiency (SCID).
    Touraine JL
    Birth Defects Orig Artic Ser; 1983; 19(3):139-42. PubMed ID: 6360231
    [No Abstract]   [Full Text] [Related]  

  • 44. Graft versus host reactions in foals with combined immunodeficiency.
    Perryman LE; Liu IK
    Am J Vet Res; 1980 Feb; 41(2):187-92. PubMed ID: 6989299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Indications and limitations of bacteriological isolation in severe combined immunologic deficiencies].
    Mozziconacci P
    Nouv Presse Med; 1974 Jun; 3(22):1419-20. PubMed ID: 4601859
    [No Abstract]   [Full Text] [Related]  

  • 46. Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections.
    Warren RP; Storb R; Weiden PL; Mickelson EM; Thomas ED
    Transplantation; 1976 Dec; 22(6):631-5. PubMed ID: 137561
    [No Abstract]   [Full Text] [Related]  

  • 47. Histocompatibility in humans.
    Fotino M
    Ann Clin Lab Sci (1971); 1971; 1(2):125-30. PubMed ID: 4405210
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of genetically defined nude mice in the study of the mixed leukocyte reaction.
    Croy BA; Osoba D
    J Immunol; 1974 Nov; 113(5):1626-34. PubMed ID: 4278870
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunological dysregulation after bone-marrow transplantation in patients with severe combined immunodeficiency.
    Virelizier JL; Durandy A; Ballet JJ; Griscelli C
    Pathol Biol (Paris); 1978 Jan; 26(1):21-2. PubMed ID: 29268
    [No Abstract]   [Full Text] [Related]  

  • 50. Thymus function and reconstitution of immunodeficiency.
    Zinkernagel RM
    N Engl J Med; 1978 Jan; 298(4):222. PubMed ID: 304177
    [No Abstract]   [Full Text] [Related]  

  • 51. The use of cell separation techniques and isantibody to host antigens in the treatent of severe combined immunodeficiency disease with HL-A incompatible maternal marrow.
    Gelfand EW; Phillips RA; Miller RG; McCulloch EA; Rosen FS
    Exp Hematol; 1974; 2(3):122-30. PubMed ID: 4156326
    [No Abstract]   [Full Text] [Related]  

  • 52. In vitro lymphocyte response of patients with immunologic deficiency diseases.
    Rocklin RE; Rosen FS; David JR
    N Engl J Med; 1970 Jun; 282(24):1340-3. PubMed ID: 5444647
    [No Abstract]   [Full Text] [Related]  

  • 53. Cell-mediated immunity: mechanisms, significance, and evaluation.
    Papageorgiou PS
    Pediatr Ann; 1976 Jun; 5(6):378-96. PubMed ID: 5697
    [No Abstract]   [Full Text] [Related]  

  • 54. Transfer factor I: methods of therapy.
    Levin AS; Spitler LE; Fudenberg HH
    Birth Defects Orig Artic Ser; 1975; 11(1):445-8. PubMed ID: 1080060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reconstitution of immunologic function in a patient with severe combined immunodeficiency following transplantation of marrow from an HLA-A,B,C nonidentical but MLC-compatible paternal donor.
    O'Reilly RJ; Kapoor N; Pollack M; Sorell M; Chaganti RS; Blaese RM; Wank R; Good RA; Dupont B
    Transplant Proc; 1979 Dec; 11(4):1934-7. PubMed ID: 43615
    [No Abstract]   [Full Text] [Related]  

  • 56. [Letter: Implantation of fetal thymus during the terminal period of Hodgkin's disease. Immunologic and histological data].
    Lang JM; Oberling F; Lacroute JM; Mayer S; Brettes PH
    Nouv Presse Med; 1975 Feb; 4(7):509. PubMed ID: 1079342
    [No Abstract]   [Full Text] [Related]  

  • 57. Developmental aspects of delayed hypersensitivity.
    Berkel AI
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:147-51. PubMed ID: 4277433
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunological deficiency syndrome in non-identical twins: maintenance in a gnotobiotic state and attempts at treatment with transplants of bone marrow and foetal thymus.
    Flad HD; Genscher U; Dietrich M; Krieger D; Trepel FW; Hochapfel G; Teller W; Fliedner TM
    Rev Eur Etud Clin Biol; 1971 Apr; 16(4):328-34. PubMed ID: 4935467
    [No Abstract]   [Full Text] [Related]  

  • 59. Genetic and cellular control of in vitro models of allograft reactivity.
    Bach FH; Alter BJ; Schendel DJ; Segall M; Bach ML
    Birth Defects Orig Artic Ser; 1975; 11(1):467-76. PubMed ID: 238687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fatal lymphoma after transplantation of cultured thymus in children with combined immunodeficiency disease.
    Borzy MS; Hong R; Horowitz SD; Gilbert E; Kaufman D; DeMendonca W; Oxelius VA; Dictor M; Pachman L
    N Engl J Med; 1979 Sep; 301(11):565-8. PubMed ID: 157433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.